Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMG8P24)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Acetamidobenzenesulfonamide; 121-61-9; N-(4-Sulfamoylphenyl)acetamide; Acetylsulfanilamide; Neotherapol; p-Sulfamylacetanilide; N4-ACETYLSULFANILAMIDE; Erytrin; N4-Acetsulfanilamide; 4-Acetylaminobenzenesulfonamide; 4'-Sulfamylacetanilide; 4'-Sulfamoylacetanilide; Sulfanilamide-N4-acetate; p-Sulfamoylacetanilide; p-Acetamidobenzenesulfonamide; N'-Acetylsulphanilamide; 4'-Sulphamoylacetanilide; N-(4-Sulphamoylphenyl)acetamide; Benzenesulfonamide, p-acetamido-; p-(Acetylamino)benzenesulfonamide; Acetanilide, 4'-sulfamoyl-
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||||||||